Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8582 |
High Similarity |
NPD9133 |
Approved |
0.8444 |
Intermediate Similarity |
NPD9628 |
Approved |
0.8273 |
Intermediate Similarity |
NPD1451 |
Approved |
0.8261 |
Intermediate Similarity |
NPD875 |
Clinical (unspecified phase) |
0.8143 |
Intermediate Similarity |
NPD9183 |
Clinical (unspecified phase) |
0.8028 |
Intermediate Similarity |
NPD9627 |
Approved |
0.7958 |
Intermediate Similarity |
NPD568 |
Approved |
0.7958 |
Intermediate Similarity |
NPD567 |
Approved |
0.7958 |
Intermediate Similarity |
NPD566 |
Approved |
0.7682 |
Intermediate Similarity |
NPD2604 |
Approved |
0.7682 |
Intermediate Similarity |
NPD3697 |
Discontinued |
0.7667 |
Intermediate Similarity |
NPD2180 |
Approved |
0.7647 |
Intermediate Similarity |
NPD300 |
Approved |
0.76 |
Intermediate Similarity |
NPD1731 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD3130 |
Discontinued |
0.723 |
Intermediate Similarity |
NPD5342 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD3108 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD3105 |
Discontinued |
0.6986 |
Remote Similarity |
NPD576 |
Discontinued |
0.6937 |
Remote Similarity |
NPD5768 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD9132 |
Discontinued |
0.6624 |
Remote Similarity |
NPD3708 |
Phase 2 |
0.6557 |
Remote Similarity |
NPD3497 |
Clinical (unspecified phase) |
0.6466 |
Remote Similarity |
NPD8859 |
Approved |
0.6466 |
Remote Similarity |
NPD8861 |
Approved |
0.6466 |
Remote Similarity |
NPD8862 |
Approved |
0.6412 |
Remote Similarity |
NPD1037 |
Clinical (unspecified phase) |
0.6346 |
Remote Similarity |
NPD3706 |
Clinical (unspecified phase) |
0.634 |
Remote Similarity |
NPD1808 |
Phase 1 |
0.6282 |
Remote Similarity |
NPD582 |
Approved |
0.6241 |
Remote Similarity |
NPD757 |
Phase 3 |
0.623 |
Remote Similarity |
NPD7465 |
Suspended |
0.6209 |
Remote Similarity |
NPD1120 |
Approved |
0.6209 |
Remote Similarity |
NPD1121 |
Approved |
0.619 |
Remote Similarity |
NPD1388 |
Phase 1 |
0.619 |
Remote Similarity |
NPD1389 |
Clinical (unspecified phase) |
0.619 |
Remote Similarity |
NPD1390 |
Phase 1 |
0.6173 |
Remote Similarity |
NPD7842 |
Phase 2 |
0.6133 |
Remote Similarity |
NPD1807 |
Clinical (unspecified phase) |
0.6089 |
Remote Similarity |
NPD1308 |
Approved |
0.6081 |
Remote Similarity |
NPD9544 |
Approved |
0.6081 |
Remote Similarity |
NPD78 |
Approved |
0.6067 |
Remote Similarity |
NPD2137 |
Approved |
0.6067 |
Remote Similarity |
NPD2138 |
Approved |
0.6062 |
Remote Similarity |
NPD8261 |
Discontinued |
0.6039 |
Remote Similarity |
NPD1119 |
Phase 2 |
0.6037 |
Remote Similarity |
NPD536 |
Clinical (unspecified phase) |
0.6013 |
Remote Similarity |
NPD1431 |
Approved |
0.6013 |
Remote Similarity |
NPD2253 |
Discontinued |
0.6013 |
Remote Similarity |
NPD1430 |
Approved |
0.5987 |
Remote Similarity |
NPD9632 |
Phase 3 |
0.5987 |
Remote Similarity |
NPD9081 |
Clinical (unspecified phase) |
0.596 |
Remote Similarity |
NPD8271 |
Discontinued |
0.5942 |
Remote Similarity |
NPD9626 |
Clinical (unspecified phase) |
0.5941 |
Remote Similarity |
NPD3083 |
Approved |
0.5931 |
Remote Similarity |
NPD1368 |
Approved |
0.593 |
Remote Similarity |
NPD1623 |
Approved |
0.5894 |
Remote Similarity |
NPD1085 |
Approved |
0.5894 |
Remote Similarity |
NPD1775 |
Approved |
0.5888 |
Remote Similarity |
NPD5679 |
Clinical (unspecified phase) |
0.5888 |
Remote Similarity |
NPD4341 |
Clinical (unspecified phase) |
0.5888 |
Remote Similarity |
NPD7557 |
Clinical (unspecified phase) |
0.5862 |
Remote Similarity |
NPD9582 |
Phase 3 |
0.5849 |
Remote Similarity |
NPD549 |
Approved |
0.5844 |
Remote Similarity |
NPD9650 |
Phase 3 |
0.5839 |
Remote Similarity |
NPD174 |
Discontinued |
0.5829 |
Remote Similarity |
NPD8641 |
Approved |
0.5806 |
Remote Similarity |
NPD547 |
Clinical (unspecified phase) |
0.5796 |
Remote Similarity |
NPD252 |
Clinical (unspecified phase) |
0.5793 |
Remote Similarity |
NPD775 |
Approved |
0.5789 |
Remote Similarity |
NPD515 |
Phase 1 |
0.5782 |
Remote Similarity |
NPD578 |
Discontinued |
0.5775 |
Remote Similarity |
NPD613 |
Phase 2 |
0.5752 |
Remote Similarity |
NPD1127 |
Approved |
0.5752 |
Remote Similarity |
NPD1128 |
Approved |
0.5749 |
Remote Similarity |
NPD9605 |
Phase 3 |
0.5747 |
Remote Similarity |
NPD1777 |
Approved |
0.5747 |
Remote Similarity |
NPD1776 |
Approved |
0.5732 |
Remote Similarity |
NPD194 |
Clinical (unspecified phase) |
0.5731 |
Remote Similarity |
NPD1335 |
Approved |
0.5724 |
Remote Similarity |
NPD281 |
Approved |
0.5705 |
Remote Similarity |
NPD545 |
Clinical (unspecified phase) |
0.57 |
Remote Similarity |
NPD8292 |
Phase 2 |
0.5699 |
Remote Similarity |
NPD2807 |
Discontinued |
0.5696 |
Remote Similarity |
NPD535 |
Approved |
0.568 |
Remote Similarity |
NPD2662 |
Approved |
0.568 |
Remote Similarity |
NPD510 |
Phase 1 |
0.568 |
Remote Similarity |
NPD2660 |
Approved |
0.5674 |
Remote Similarity |
NPD9345 |
Clinical (unspecified phase) |
0.5674 |
Remote Similarity |
NPD9371 |
Clinical (unspecified phase) |
0.5674 |
Remote Similarity |
NPD9196 |
Phase 2 |
0.5669 |
Remote Similarity |
NPD209 |
Clinical (unspecified phase) |
0.5667 |
Remote Similarity |
NPD8119 |
Discontinued |
0.5661 |
Remote Similarity |
NPD8113 |
Phase 2 |
0.5652 |
Remote Similarity |
NPD7245 |
Approved |
0.5652 |
Remote Similarity |
NPD7246 |
Clinical (unspecified phase) |
0.5649 |
Remote Similarity |
NPD870 |
Clinical (unspecified phase) |
0.5641 |
Remote Similarity |
NPD282 |
Approved |
0.5638 |
Remote Similarity |
NPD307 |
Approved |
0.5629 |
Remote Similarity |
NPD962 |
Phase 3 |
0.5618 |
Remote Similarity |
NPD3347 |
Clinical (unspecified phase) |
0.561 |
Remote Similarity |
NPD249 |
Approved |
0.561 |
Remote Similarity |
NPD250 |
Approved |
0.5602 |
Remote Similarity |
NPD1174 |
Phase 2 |
0.56
|
Remote Similarity |
NPD9409 |
Discontinued |